Common Use

Viibryd (vilazodone) is a prescription antidepressant medication used for the treatment of major depressive disorder (MDD) in adults. As a selective serotonin reuptake inhibitor (SSRI) and serotonin 5-HT1A receptor partial agonist, Viibryd features a unique dual mechanism of action that helps restore the balance of serotonin in the brain. This medication effectively reduces the hallmark symptoms of depression, including persistent sadness, loss of interest in daily activities, feelings of worthlessness, anxiety, sleep disturbances, and decreased energy levels. Viibryd may improve your overall emotional well-being, motivation, and ability to engage in everyday life. It is intended for long-term management of depression under ongoing medical supervision. Many patients who buy Viibryd online find it to be a well-tolerated antidepressant with a favorable side effect profile.

Dosage and Direction

Viibryd should be taken exactly as prescribed by your healthcare provider. It is typically taken once daily with food, as taking vilazodone with food significantly improves its absorption by up to 70%. Treatment usually begins with a 10 mg dose for the first 7 days, then increases to 20 mg daily for another 7 days, before reaching the target dose of 40 mg once daily. This gradual titration schedule helps minimize side effects. Do not stop taking Viibryd abruptly, as sudden discontinuation may cause withdrawal symptoms such as irritability, dizziness, nausea, and sensory disturbances. Your doctor will guide you through a gradual tapering schedule if you need to stop the medication.

Precautions

Before starting Viibryd, inform your doctor if you have a history of bipolar disorder, seizure disorder, liver problems, bleeding disorders, or glaucoma. Vilazodone, like all antidepressants, carries a boxed warning about the potential increased risk of suicidal thoughts and behaviors, particularly in young adults under 25 years old during the initial weeks of treatment or when the dose is changed. Close monitoring by family members and healthcare providers is essential during these periods. Avoid alcohol consumption during treatment, as it may worsen side effects including drowsiness and impaired judgment. Regular follow-up appointments with your healthcare provider are strongly recommended to assess treatment progress and adjust therapy as needed.

Contraindications

Viibryd is contraindicated in patients with hypersensitivity to vilazodone hydrochloride or any of its components. It must not be used concurrently with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI, due to the risk of serious and potentially fatal serotonin syndrome. Similarly, do not start an MAOI within 14 days of discontinuing Viibryd. This medication should not be used with intravenous methylene blue or linezolid. Use during pregnancy should only occur when the potential benefits justify the risk to the fetus. Vilazodone is not approved for use in pediatric patients.

Possible Side Effects

Common side effects of Viibryd include diarrhea, nausea, vomiting, dizziness, insomnia, and dry mouth. Some patients may experience headache, fatigue, abnormal dreams, or decreased appetite. Sexual side effects such as decreased libido may occur but tend to be less frequent than with traditional SSRIs. Most side effects are mild to moderate in severity and often decrease over time as your body adjusts. Serious but rare side effects include serotonin syndrome (symptoms: agitation, hallucinations, rapid heartbeat, fever, muscle stiffness), hyponatremia (low sodium levels), abnormal bleeding, or manic episodes. Seek immediate medical attention if severe or unusual symptoms occur.

Drug Interaction

Viibryd may interact with other serotonergic medications including other SSRIs, SNRIs, triptans, tramadol, and St. John's Wort, significantly increasing the risk of serotonin syndrome. Strong CYP3A4 inhibitors such as ketoconazole may increase vilazodone levels, requiring dose reduction. CYP3A4 inducers such as carbamazepine may decrease its effectiveness. Combining Viibryd with anticoagulants, antiplatelet agents, or NSAIDs may increase bleeding risk. Avoid use with drugs that prolong the QT interval. Always inform your doctor about all medications, supplements, and herbal products you are taking.

Missed Dose

If you miss a dose of Viibryd, take it as soon as you remember with food for proper absorption. If it is close to the next scheduled dose, skip the missed one. Do not take two doses at the same time. Consistent daily dosing is important for maintaining stable antidepressant effects. Continue with your regular dosing schedule.

Overdose

Symptoms of Viibryd overdose may include nausea, vomiting, diarrhea, confusion, disorientation, serotonin syndrome symptoms, lethargy, or rapid heartbeat. Seek immediate emergency medical attention if an overdose is suspected. Do not exceed the prescribed dose. Supportive medical care, including cardiac monitoring and symptomatic treatment, may be required. There is no specific antidote for vilazodone overdose.

Storage

Store Viibryd at room temperature between 15-30 degrees C (59-86 degrees F), away from moisture and heat. Keep the medication in its original container with the cap tightly closed. Protect from direct sunlight. Keep Viibryd out of reach of children and pets.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.